Clinical Trial Update: A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 study of tazemetostat in adult participants with soft tissue sarcoma, including rhabdoid tumors, has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Chordoma
• Epithelioid Sarcoma
• Malignant Rhabdoid Tumor
• Malignant Rhabdoid Tumor of Ovary
• Renal Medullary Carcinoma
• Rhabdoid Tumor of the Kidney
• Synovial Sarcoma

Drugs mentioned

• Tazemetostat (tazemetostat)

Snippet

Sponsor: Epizyme, Inc. | Conditions: Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK) | Phase 2 | Status: COMPLETED | Results posted: 2025-03-11